Liver Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 80 years, of any gender
- People who have been diagnosed with liver cancer (either starting in the liver or spreading to the liver from elsewhere), confirmed by tissue testing or clinical assessment
- People who have at least one liver tumour that can be measured on imaging scans, where the largest tumour measures between 3 and 5 centimetres across
- People who are unable to tolerate surgery or who have chosen not to have surgery
- People who are reasonably well and able to carry out basic daily activities (based on a standard health scoring system), with a life expectancy of more than 3 months
Who may not be able to join:
- People with severely reduced liver function that cannot be improved with liver-protecting treatments (confirm with trial site)
- People with a very large or widely spread form of liver cancer throughout the liver
- People whose cancer has grown into nearby blood vessels or spread into surrounding organs
- People who have had a bleeding episode from enlarged veins in the oesophagus or stomach within the past month
- People with serious blood clotting problems or significant blood abnormalities that cannot be corrected, where there is a high risk of major bleeding
- People with large amounts of fluid in the abdomen that does not respond to treatment, or with severe muscle and weight loss
- People with an active infection, particularly involving the bile ducts or biliary system
- People with serious loss of function in major organs such as the liver, kidneys, heart, lungs, or brain
- People who are not fully conscious or who are unable to cooperate with the treatment process
- People who have received systemic treatments such as chemotherapy within the past 2 weeks and have not yet recovered from the side effects of those treatments (confirm with trial site)
- People who, in the opinion of the trial doctors, have any other reason that makes participation unsuitable or that may affect their involvement in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 13774225887
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Ablation efficacy rate at 1 month postoperatively
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.